Beazley launches life sciences offering in Asia Pacific

Beazley launches life sciences offering in Asia Pacific

For more information

Beazley launches life sciences offering in Asia Pacific

Specialist insurer Beazley has launched a suite of covers to protect organisations within Asia Pacific’s innovative and rapidly expanding life sciences sector.

In an environment in which risk exposures are complex and varied, from the release of unsafe medical devices and medicines, to negligence in human testing, through to the mismanagement of clinical trials and drug discovery, Beazley’s offering is designed to provide organisations with holistic coverage that avoids unnecessary gaps in their insurance cover.

The cover includes:

  • Products liability
  • Professional indemnity
  • Public liability
  • Medical malpractice
  • Clinical research services – negligent act, error or omission
  • Clinical trials – no-fault compensation & legal liability

This launch builds on Beazley’s experience in writing life sciences risks globally for more than 20 years. It is led by underwriters and claims specialists who bring a deep understanding of the risk landscape to ensure the offering is flexible and tailored to the needs of the sector. The policy has been designed to be clearly worded and intuitive to use, which health, wellness and life sciences professionals based in Asia have highlighted as a key priority, according to recent research by Beazley.*

Among the many types of organisation that can benefit from Beazley’s specialist life sciences cover are medical device manufacturers, contract research organisations, biotechnology & biologics, pharmaceuticals, nutraceuticals (including cosmetics and skincare), prescription & over the counter injectables/ topicals and oral drugs, and pharmaceutical support services, clinical trials, vaccines and testing laboratories.

Prashansa Daga, Healthcare Underwriter said: “The life sciences sector across Asia has been growing significantly in recent years and has already overtaken EU in terms of size*. Asia Pacific is now the second largest market in terms of size after the US. Covid-19 has also exposed the need for self-reliance amongst different countries in the region as we saw closing of borders, restriction on movement of pharmaceutical ingredients and the global vaccine scramble. The response to Covid-19 has also fuelled a race to create tests, vaccines and treatments. As an industry driven by intrinsic innovation and inelastic demand for patient needs, life sciences is expected to see significant growth in years to come. Our policy provides clear, broad and flexible cover for a range of risks to help this diverse sector to manage its risk exposures and continue to expand and thrive.”

Evan Smith, Global Head of Miscellaneous Medical & Life Sciences at Beazley, said: “We’ve been writing life sciences risks at Beazley for over two decades and today, we have a well-established book in North America and the UK, and as demand has grown internationally we are taking our lessons-learned and are tailoring policies for new territories. Clients and brokers will be well supported by our technically skilled team of underwriting and claims specialists based in Singapore.”

For any assistance contact HDL

At HDL, our ability to design insurance solutions for the life sciences industry and service the needs of our multinational clients is virtually boundless. We have access to licensed insurers worldwide, with local representation in over 140 countries.

Contact HDL for more information.

The information provided in this article is of a general nature only and has been prepared without taking into account your individual objectives, financial situation or needs. If you require advice that is tailored to your specific business or individual circumstances, please contact HDL.

HDL news, updates and publications may contain links to non-HDL websites that are created and controlled by other organisations. We claim no responsibility for the content of any linked website, or any link contained therein. The inclusion of any link does not imply endorsement by HDL, as we have no responsibility for information referenced in material owned and controlled by other parties. HDL strongly encourages you to review any separate terms of use and privacy policies governing use of these third party websites and resources.

Find this article helpful? Click on one of the links below to share the content.